NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Presentation outlines benefits of the digital asset treasury model and Upexi-specific plans TAMPA, FL / ACCESS Newswire / May 27, 2025 /Upexi, Inc. (NASDAQ:UPXI), a brand owner specializing in the ...

Poster Presentation Title: No Association between Decreases in ... Further discussion about these and other risks and uncertainties can be found in our Annual Report on Form 10-K for the fiscal year ...

Poster Presentation Title ... discussion about these and other risks and uncertainties can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in our ...

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 07.2025 27.05.2025 TRESU Investment Holding A/S – Announcement of Q1 2025 Interim Report Tresu Investment Holding A/S today publishes the Q1 2025 Interim ...

Net Revenue: $1.895 billion, a new record, grew by 63% year-on-year Q1 Gross Margin: 50.3% GAAP gross margin; 59.8% non-GAAP gross margin Q1 Diluted income per ...

Cyprus recorded €43.8 million in high-value property transactions in April 2025, marking a 52.8 per cent drop compared to ...

Amalfe brings that management experience—and decades of service to the New Jersey State Bar Association—to the role of NJSBA ...

KELOWNA, BC / ACCESS Newswire / May 30, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

BioNTech SE(Nasdaq: BNTX, "BioNTech" or "the Company") will present clinical trial data from select pipeline candidates across the Company's diversified oncology portfolio ...